Understand the bias, discover the truth in your news. Get Started
RTE Article Rating

Pfizer does deal with Trump on prescription drug prices

  • Bias Rating
  • Reliability

    35% ReliableAverage

  • Policy Leaning

    28% Somewhat Right

  • Politician Portrayal

    -14% Negative

Bias Score Analysis

The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.

Sentiments

Overall Sentiment

11% Positive

  •   Liberal
  •   Conservative
SentenceSentimentBias
Unlock this feature by upgrading to the Pro plan.

Bias Meter

Extremely
Liberal

Very
Liberal

Moderately
Liberal

Somewhat Liberal

Center

Somewhat Conservative

Moderately
Conservative

Very
Conservative

Extremely
Conservative

-100%
Liberal

100%
Conservative

Bias Meter

Contributing sentiments towards policy:

70% : "The United States is done subsidising the healthcare of the rest of the world," Trump said, speaking at an event in the Oval Office accompanied by Pfizer CEO Albert Bourla, Health Secretary Robert F Kennedy Jr and others.
58% : Given that Medicaid already benefits from substantial discounts and rebates - exceeding 80% in certain cases - the incremental impact on manufacturers is relatively minimal.
53% : More than 70 million people are covered by Medicaid, the state and federal government programme for low-income people.
52% : Anna Kaltenboeck, a health economist at Verdant Research, said that if Pfizer and other companies provide supplemental rebates to Medicaid, that could be significant, as it would support states struggling with the cost of specialty drugs.
51% : According to a poster on display at the event, those will include rheumatoid arthritis drug Xeljanz, which carries a list price of over $6,000 a month, migraine treatment Zavzpret, dermatitis drug Eucrisa and post-menopausal osteoporosis medication Duavee. Drugmakers' shares rose because the price concessions are limited to Medicaid, said Daniel Barasa, portfolio manager at investment firm Gabelli Funds.
51% : if the reductions applied to Medicare, she said.
47% : Trump also said Pfizer would offer that most-favoured-nation pricing on all new drugs launched in the US and flagged that other drugmakers will follow suit.
47% : On September 25, Trump announced he would impose a 100% tariff on imports of branded or patented pharmaceutical products from October 1, unless a drugmaker is building a manufacturing plant in the US.
44% : US patients currently pay by far the most for prescription medicines, often nearly three times more than in other developed nations, and Trump has been pressuring drugmakers to lower their prices to what patients pay elsewhere.
42% : Trump sent letters to 17 leading drug companies in July telling them to slash prices to match those paid overseas.
40% : Medicaid spends less on drugs than other payers, however, so the impact would be less dramatic than
27% : Pfizer and US President Donald Trump said they had cut a deal in which the US-based drugmaker agreed to lower prescription drug prices in the Medicaid programme to what it charges in other developed countries in exchange for tariff relief.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.

Category
Topic
Copy link